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The proliferation and possible adverse effects of emerging contaminants such as 21 
pharmaceutical and personal care products (PPCPs) in waters and the environment is 22 
causing increased concern. We investigated the dissipation of three PPCPs: ibuprofen 23 
(IBP), diclofenac (DCF) and triclosan (TCS), separately or in mixture, in the ppm range 24 
in microcosm biopurification systems (BPS), paying special attention to their effect on 25 
bacterial ecotoxicity and on bacterial community structure and composition. The results 26 
reveal that the BPS efficiently dissipates IBP and DCF with 90% removal after 45 and 27 
84 days of incubation, respectively. However, removal of TCS required longer 28 
incubation, 127 days for 90% removal. Furthermore, dissipation of the three PPCPs was 29 
slower when all three were applied to the BPS as a mixture. TCS had an initial negative 30 
effect on bacterial viability by a decrease of 34-43%; however, this effect was mitigated 31 
when all three PPCPs were present simultaneously. The bacterial communities in the 32 
BPS were affected much more by incubation time than by the applied PPCPs. 33 
Nonetheless, the PPCPs affected differentially the composition and relative abundance 34 
of bacterial taxa. IBP and DCF initially increased bacterial diversity and richness while 35 
exposure to TCS generally provoked the opposite effect. TCS had the largest effect on 36 
bacterial groups negatively affecting the relative abundance of Acidobacteria, 37 
Rickettsiales, Methylophilales, Methylacidiphilae and Phycisphaerae. On the other 38 
hand, all three PPCPs stimulated the dominant bacterial families 39 
Promicromonosporaceae, Caulobacteraceae, Xanthomonadaceae, Cyclobacteriaceae, 40 
Sphingobacteriaceae and Verrucomicrobiaceae, whose members could harbour 41 
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1. Introduction 60 
Pharmaceuticals and personal care products (PPCPs) used as medicinal drugs or to 61 
improve the quality of daily life, are being considered emerging contaminants of public 62 
concern. PPCPs are increasingly being detected in the aquatic environments, such as 63 
water, sediment and biota (Ebele et al., 2017; Peng et al., 2019). The presence of PPCPs 64 
in surface water may have negative ecological impacts even at low concentrations, due 65 
to their continuous introduction into environments through different anthropogenic 66 
sources (Houtman, 2010; Ebele et al., 2017). In rural areas with low population 67 
densities, untreated sewage is directly discharged into the sea or rivers (Daughton and 68 
Ternes, 1999). However, effluents from wastewater treatment plants (WWTP) are the 69 
main route of entry of PPCPs into the aquatic environment (Petrović et al., 2003; 70 
Castiglioni et al., 2005; Rosal et al., 2010). Among PPCPs, two non-steroidal anti-71 
inflammatory drugs: ibuprofen (IBP) and diclofenac (DCF), and the antimicrobial agent 72 
triclosan (TCS) are commonly detected in surface water at concentrations of ng per litre 73 
(ppb) (Wilkinson et al., 2017). These contaminants have been shown to pose harmful 74 
effects on aquatic organisms such as fish, algae and invertebrates (Lonappan et al., 75 
2016; Olaniyan et al., 2016). Moreover, TCS which has been detected in drinking water 76 
and in plants cultivated in soils amended with biosolids from WWTPs, or irrigated with 77 
sewage, is an important risk for human health because it can cause endocrine disruption 78 
and affect different tissues (Gee et al., 2008; Jung et al., 2012; Geens et al., 2012). 79 
Therefore, the development of an appropriate technology is required that allows the 80 
efficient removal of PPCPs before effluent discharge (Grassi et al., 2013).  81 
Bioremediation strategies include biopurification systems (BPS), also known as 82 
biobeds, which have been used successfully on-farm to remove organic pollutants from 83 
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wastewaters, and are being implemented as a system to control point-source 84 
contamination (De Wilde et al., 2007; Castillo et al., 2008; Dias et al.,, 2020; Karas et 85 
al., 2016). The main substrate of BPS is a biomixture of topsoil and organic materials 86 
which harbours indigenous microorganisms which can become adapted to eliminate 87 
these pollutants (Castillo Diaz et al., 2016; Aguilar-Romero et al., 2019). Recently, 88 
Delgado-Moreno et al. (2019) suggested that BPS based on a biomixture composed of 89 
agro-industrial olive oil waste, as available and sustainable local organic materials, 90 
could be a workable strategy to remove PPCPs from wastewaters generated by the 91 
pharmaceutical industry, hospitals, or effluents from wastewater treatment plants. 92 
As has been documented, the efficiency of the BPS to remove contaminants such as 93 
pesticides must be ascribed to the functioning and resilience of the microbial 94 
communities of the BPS (Marinozzi et al., 2013; Tortella et al., 2013; Dealtry et al., 95 
2016; Castro-Gutiérrez et al., 2017; Diez et al., 2017, 2018; Holmsgaard et al., 2017; El 96 
Azhari et al., 2018; Góngora-Echeverría et al., 2018). However, little is known 97 
regarding the impact of PPCPs on the microbial population of this system. The current 98 
study investigates the potential removal of three PPCPs, alone and in mixture, in BPS 99 
microcosms; how interactions between contaminants can affect their dissipation 100 
kinetics, their possible toxic effects on the indigenous microbial community of the BPS, 101 
as well as the principal bacterial groups potentially involved in the bioremoval of these 102 
PPCPs.  103 
2. Materials and methods 104 
2.1 Chemicals  105 
Ibuprofen (IBP) (≥ 98% purity), diclofenac sodium salt (DCF) (≥ 98.5% purity) and 106 
triclosan (TCS) (> 97% purity) were purchased from Sigma-Aldrich (Steinheim, 107 
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Germany). HPLC-grade solvents from Scharlau (Barcelona, Spain) and MilliQ water 108 
were used. 109 
2.2 Degradation study in BPS microcosms 110 
Biopurification systems (BPSs) were constructed at microcosm scale with a biomixture 111 
containing an agricultural silty clay loam soil, vermicompost of wet olive cake and olive 112 
tree prunings (1:1:2, v:v:v). Physicochemical properties of the biomixture were 113 
described by Delgado-Moreno et al. (2019). Each BPS was prepared in triplicate and the 114 
biomixture contaminated with either 100 µg g-1 of IBP, 20 µg g-1 of DCF or 20 µg g-1 of 115 
TCS, or all together as a mixture. The quantity of IBP was 5 times higher than the other 116 
compounds due to its reported fast dissipation in BPS (Delgado-Moreno et al., 2019). 117 
For this purpose, 1 g of silica sand placed in a 200 mL glass container used to house the 118 
microcosms was spiked with a solution of acetone containing each compound, either 119 
separately or as a mixture. After solvent evaporation, 60 g of the biomixture was added 120 
and mixed in an end-over-end rotary shaker for 15 min at room temperature. The 121 
biomixtures were moistened to 75% of their field capacity and the microcosms were 122 
incubated in darkness in a thermostatic chamber at 20ºC. The moisture content was 123 
maintained by adding sterile distilled water weekly. Autoclaved biomixtures were 124 
prepared in parallel as an abiotic control as described by Aguilar-Romero et al. (2019). 125 
BPSs with non-contaminated biomixtures were run in parallel to determine the effect 126 
caused by experimental conditions on the microbial populations. For work-up, the 127 
PPCPs were extracted at 0, 7, 14, 21, 50 and 79 days from 3 g (dry-weight) of 128 
biomixture by adding 6 ml of acetonitrile acidified with 1% acetic acid and vortexing 129 
for 1 min. Then, 1 g of a salts mixture (QuEChERS EN Pouch, Agilent Technologies, 130 
Santa Clara, CA, USA) was added and vortexed again for 1 min. Samples were 131 
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centrifuged for 5 min at 3500 rpm, filtered with a 0.45 µm PTFE filter and analysed by 132 
high-performance liquid chromatography (HPLC, series 1100 system, Agilent 133 
Technologies), using the conditions described by Delgado-Moreno et al. (2019). The 134 
extraction method recoveries for IBP, DCF and TCS were 87%-92%, 82%-90% and 135 
82%-106%, respectively (Delgado-Moreno et al., 2019). 136 
2.3 Total DNA isolation and amplicon sequencing analysis 137 
To determine the effect of PPCPs on the indigenous bacterial community, total genomic 138 
DNA was extracted from 0.5 g (wet weight) of biomixture from each microcosm-scale 139 
BPS at different times using the FastDNA® Spin Kit for soil (MP Biomedicals, Solon, 140 
OH, USA). The DNA was quantified by using the Qubit dsDNA BR Assay kit (Live 141 
Technologies, Invitrogen, USA). Then, DNA samples were submitted for high-142 
throughput 16S rRNA gene amplicon sequencing to Integrated Microbiome Resource 143 
(www.cgeb-imr.ca, Halifax, Nova Scotia, Canada). Primers for the V4-V5 variable 144 
regions of the 16S rRNA gene (Walters et al., 2015) were used and the amplified 145 
products were sequenced with Illumina MiSeq using 2 x 300 bp PE v3 chemistry 146 
(Comeau et al., 2017). All sequence files were submitted to the National Center for 147 
Biotechnology Information (NCBI) Sequence Read Archive (SRA - 148 
https://www.ncbi.nlm.nih.gov/sra) and are accessible in BioProject PRJNA603893. 149 
2.4 Bioinformatic data analysis 150 
Bacterial 16S V4-V5 region sequences were processed using QIIME version 1.9.0 151 
(Caporaso et al., 2010b). Forward and reverse sequences were joined, fastq files were 152 
filtered for quality (Phred 20) and potential chimeras were detected and removed from 153 
the dataset using usearch61 (Edgar et al., 2011). The remaining sequences were 154 
clustered into Operational Taxonomic Units (OTUs) at 97% similarity level following 155 
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an open reference OTU picking strategy using UCLUST (Edgar et al., 2011). 156 
Representative sequences of each OTU were aligned against SILVA database (v132; 157 
(Quast et al., 2013)) using PyNAST (Caporaso et al., 2010a). 158 
2.5 Real-Time PCR quantification (qPCR) 159 
The total bacterial community and the abundance of Acidobacteria and Alpha-, Beta- 160 
and Gammaproteobacteria were quantified by real-time PCR assays using the taxon-161 
specific 16S rRNA primers and thermal conditions described by Philippot et al. (2011). 162 
The real-time PCR reactions were carried out in 12.5 µl of volume using 6.25 µl of 163 
iQ™ SYBR® Green Supermix (Bio-Rad Laboratories, Hercules, CA, USA), 400 nM of 164 
each primer and 1 ng of DNA. All samples were run in triplicate. Serial dilutions of 165 
linearized pCR2.1-TOPO® containing cloned sequences of the 16S rRNA gene specific 166 
for each taxa were used for standard curves. The PCR efficiency values ranged between 167 
81 and 103%. To check for the presence of inhibitors in the DNA used for qPCR assays, 168 
DNA samples from biomixtures were mixed with a known amount of standard DNA 169 
prior to qPCR. No inhibitors were detected in the assays.  170 
2.6 Toxicological study 171 
To determine the toxic effects of PPCPs on the microbial populations, the number of 172 
live microorganisms was determined in non-sterile samples at different times by 173 
microscopic analyses using the LIVE/DEAD® BacLight™ Bacterial Viability Kit 174 
(Molecular Probes®, Life Technologies, USA). For this purpose, the microorganisms 175 
from 0.5 g of biomixture treated or not with PPCPs were extracted in 50 ml of 176 
phosphate buffered saline (PBS) during 1 h by shaking at 30ºC in triplicate. Then, a 177 
double concentrated working solution of the LIVE/DEAD BacLight staining reagent 178 
mixture was prepared following the manufacturer’s indications and mixed with an equal 179 
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volume of the bacterial suspension. This mixture was incubated at room temperature in 180 
the dark for 15 minutes. Cell counts were performed from 10 µl with the aid of a 181 
Neubauer chamber. 182 
2.7 Data modeling and statistical analysis 183 
To obtain the dissipation kinetics of the PPCPs in non-sterile samples, the single first-184 
order model (Ct = C0 x e-kt) was tested using the modeling program Modelmaker 4.0 185 
(Cherwell Scientific Ltd., Oxford, UK). C0 and Ct indicate the concentration (µg g-1) of 186 
PPCPs at the initial time and time t (days), respectively, and k is the dissipation rate 187 
constant (days-1). The chi-square (χ2) and scaled error values were used as criteria to 188 
ensure that the theoretical kinetics fit experimental data.  189 
Alpha diversity (Chao1, Shannon diversity index and Simpson's Evenness), and the 190 
rarefaction curves of observed OTUs were determined using QIIME based on data 191 
rarefied to the number of reads found in the least abundant sample. Similarly, QIIME 192 
was used to perform principal component analysis (PCoA) based on Bray-Curtis 193 
distances and PERMANOVA. Non-metric Multidimensional Scaling (NMDS) 194 
ordination and hierarchical cluster analysis of bacterial community composition at the 195 
phylum level based on the Bray-Curtis similarity index and the percentage of similarity 196 
between means of groups of samples (n=3) using the Unweighted Pair Group Method 197 
with Arithmetic mean (UPGMA) were determined using PAST software version 3.21 198 
(https://folk.uio.no/ohammer/past/). For these analyses, outlier sample of biomixture 2 199 
contaminated with triclosan at 7 days, T27, was not taken into account. SPSS Statistical 200 
Software Package version 25 (IBM Corporation, New York, USA) was used for one-201 




3. Results and discussion 204 
3.1 PPCP removal in BPS microcosms 205 
To determine how PPCPs affect indigenous microbial populations in BPS, the 206 
disappearance of each compound was measured along time in BPS microcosms treated 207 
with IBP, DCF, or TCS, individually or simultaneously. The dissipation curves of the 208 
PPCPs are shown in Fig. 1. The single first-order model, except in the sterile controls, 209 
accurately fitted all the experimental data showing low chi-square and scaled error 210 
values (χ5,0.052 = 11.070, errscaled < 6.24). The R2 values were over 0.92, except for TCS 211 
(Table 1). Ibuprofen showed the highest dissipation rate constant k, with 100% being 212 
removed after 79 days of incubation, although the initial concentration of IBP in the 213 
BPS was 5 fold higher than that of the other compounds. DCF and TCS dissipated more 214 
slowly than IBP and required 84 and 127 days, respectively, for 90% removal (DT90) 215 
when applied individually. The dissipation of IBP, DCF and TCS was even slower 216 
(DT90 47, 137 and 180 days respectively), when applied simultaneously. In fact, in all 217 
cases k values were higher when the PPCPs were applied separately than as a mixture 218 
(Table 1). However, the difference in this increase was only statistically significant in 219 
samples contaminated with DCF (ANOVA, p = 0.012). This indicates that DCF 220 
removal in the BPS microcosms was affected by the presence of either TCS, IBP or by 221 
both. Likely, this could be attributed to the negative effect these compounds may have 222 
on groups of microorganisms implicated in DCF dissipation. According to the results 223 
obtained by Delgado-Moreno et al. (2019) where the three PPCPs were applied as a 224 
mixture, the dissipation rates for DCF and TCS were 3 and 2 fold higher, respectively, 225 
than the values obtained in this study. Nevertheless, the amount of IBP applied in this 226 
study was 5 fold higher, which could cause a negative effect on the microbial 227 
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populations harboured in the biomixtures which are responsible for DCF and TCS 228 
dissipation. Another reason could be the existence of microorganisms with the ability to 229 
transform more than one of the compounds but which exhibit substrate preferences. For 230 
instance, Lu, Z. et al. (2019) reported that the bacterial strain Pseudoxanthomonas sp. 231 
DIN-3, which has the ability to remove DCF, IBP, and Naproxen (each at 50 µg/L), 232 
more effectively eliminated IBP than the other compounds in mixtures.  233 
On the other hand, the results from the sterilized control treatments revealed that, after 234 
79 days of incubation, the amounts of IBP, DCF and TCS which had disappeared were 235 
47.6, 7.3 and 13.43%, respectively (Fig. 1). These percentages indicate that some 236 
abiotic dissipation occurs, especially in microcosms treated with IBP. Under these 237 
conditions, the removal of PPCPs could be influenced by the presence of clay particles 238 
and solar radiation via photochemical reactions generating metabolites (Aranami and 239 
Readman, 2007; Lonappan et al., 2016; Maldonado-Torres et al., 2018). In fact, two 240 
likely abiotically formed metabolites of IBP and DCF, 1-(4-isobutylphenyl)ethanone 241 
and 2-(9H-carbazol-1-yl) acetic acid, respectively, were detected in the same type of 242 
BPS in a previous study (Delgado-Moreno et al., 2019).  243 
3.2. Bacterial community structure, dynamics and composition in the BPS microcosms 244 
To determine the response of bacterial communities to the PPCPs in the BPS 245 
microcosms, amplicon products of the V4-V5 variable regions of the 16S rRNA gene 246 
were analysed at different times. A total of 1,024,229 sequences were obtained after 247 
quality filtering and the removal of possible chimera sequences. The depth of 248 
sequencing of these samples was sufficient to cover the full diversity as indicated by 249 
rarefaction curves (Fig. S1A).  250 
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3.2.1. Bacterial richness and diversity in the BPS microcosms 251 
The diversity of the bacterial community in the BPS microcosms was determined over 252 
50 days (Table 2). In the control BPS, the bacterial richness (chao1), the number of 253 
observed OTUs, the Shannon diversity and the Simpson’s Evenness generally increased 254 
along the time with a dip at 7 to 14 days before increasing until the end of the 255 
incubation period at 50 days. Similar tendencies were observed in the BPSs exposed to 256 
PPCPs but with punctually significant differences with respect to the control. After 7 257 
days, the BPSs exposed to IBP and DCF showed significantly higher diversity and 258 
evenness. After 14 days, specifically for IBP, the richness, diversity and evenness were 259 
significantly higher than in the control. Generally, both IBP and DCF give values for 260 
richness and diversity indices higher than the control. After 50 days, the number of 261 
observed OTUs and Shannon diversity for DCF were significantly higher. Jiang et al. 262 
(2017) also observed increased Shannon diversity in sequence batch reactors exposed to 263 
IBP and/or DCF after 130 days, indicating the resilience potential of the bacterial 264 
community in response to these two non-steroidal anti-inflammatory drugs at low 265 
concentrations. In TCS-exposed BPSs, the alpha diversity parameters compared to the 266 
control were significantly reduced after 50 days (Table 2). This indicated clearly that 267 
TCS negatively affects richness and diversity of the bacterial populations of the BPS. 268 
Recent studies have demonstrated that TCS is an environmental stressor, alters the 269 
community structure and reduces species diversity and richness (Clarke et al., 2019; Oh 270 
et al., 2019; Peng et al., 2019). The simultaneous treatment with the three PPCPs gave 271 
alpha diversity values generally lower than those obtained for IBP and DCF, and higher 272 
than for TCS alone, but not significantly different from the controls, except for a higher 273 
evenness after 7 days. Therefore, the negative impact generated by TCS on its own may 274 
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be compensated by the increase in richness and diversity caused by DCF, and especially 275 
IBP. With regard to other BPS studies, increased pesticide application was shown to 276 
decrease bacterial diversity in some (Holmsgaard et al., 2017), but in others the 277 
introduced pesticides had little or transient effects (Marinozzi et al., 2013; Tortella et 278 
al., 2013; Castrro-Gutierrez et al., 2017; Diez et al., 2017, 2018; Góngora-Echeverría et 279 
al 2018; El Azhari et al 2018). These results indicate that certain pesticides had 280 
concentration-dependent effects, but mostly that BPS bacterial communities were 281 
resilient to these types of contaminants. 282 
3.2.2. Bacterial community structure and composition in the BPS microcosms 283 
The bacterial community in all the BPS microcosms was composed of 38 different 284 
phyla, 10 of which comprised 98-99% of the total OTUs detected (Fig. 2A). 285 
Proteobacteria was the most abundant phylum (38.6-57.5%), followed by Bacteroidetes 286 
(13.5-48.4%), Actinobacteria (3.6-11.2%), Planctomycetes (3.1-9.4%), Acidobacteria 287 
(0.7-6.4%) and Verrumicrobia (0.3-5.6%). Hierarchal clustering analysis of the bacterial 288 
community composition along the time grouped the bacterial communities mainly 289 
according to the contaminant applied (Fig. 2B). The main cluster showed 82% 290 
similarity between microcosms treated with DCF and the other treatments. Within this 291 
cluster, BPS microcosms treated with IBP presented a cluster of high similarity (87%) 292 
with control microcosms at 21, 28 and 50 days, while those contaminated with TCS 293 
clustered more closely with those treated simultaneously with the three PPCPs 294 
(especially at 21, 28 and 50 days). Within each subcluster, the bacterial communities at 295 
initial times (7 and 14 days) group together in all cases.  296 
Principal component analyses shows that 31.63% of the diversity variations (PC1) in 297 
bacterial community structures were affected mainly by incubation time with a higher 298 
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similarity between the communities in the initial time period (0, 7 and 14 days) than 299 
those found later at 21, 28 and 50 days (Fig. 3A). The permutational multivariate 300 
analysis of variance (PERMANOVA) of the data also indicates that the incubation time 301 
caused the greatest effect on the bacterial community composition of the BPS 302 
microcosm (PERMANOVA, p = 0.001), followed by the effect of the contamination 303 
with the different PPCPs (PERMANOVA, p < 0.005). Similarly, analyses of the 304 
bacterial communities by nonmetric multidimensional scaling (NMDS) also grouped the 305 
samples according to incubation time (Fig. S1B). Therefore, the main deterministic 306 
factor which affected the bacterial community composition of the BPSs was the 307 
incubation time and, to a lesser extent, the treatment with PPCPs. Similar stronger 308 
effects of aging of the BPS or incubation time has also been observed in other BPSs in 309 
which the effects of pesticides application were studied (Marinozzi et al., 2013; Diez et 310 
al., 2017; El Azhari et al 2018). When NMDS is constrained with data from the 311 
bacterial phyla (Fig. 3B), Bacteroidetes contributed to the bacterial community 312 
differentiation at 7 and 14 days, whereas Actinobacteria, Acidobacteria, Chloroflexi, 313 
Firmicutes and Planctomycetes showed more influence at 14 and 21 days. Nevertheless, 314 
the phyla Gemmatimonadetes, Proteobacteria, Verrumicrobia and Saccharibacteria 315 
mainly influenced the bacteria community structure at 28 and 50 days. These tendencies 316 
can also be observed in the relative abundance of these phyla in Fig. 2A in which 317 
Bacteroidetes declined with time while, in contrast, Planctomycetes, Acidobacteria and 318 
Verrumicrobia showed an opposite temporal trend, and Actinobacteria fluctuated with 319 
time, showing maximum relative abundance at 21 and 28 days. 320 
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3.2.2.1 Impact of PPCPs on the composition of the bacterial communities 321 
In order to determine the effects of the different PPCPs on the most abundant bacterial 322 
families (Fig. 4) as well as on bacterial taxa at the class/order levels (Fig. S2-S6), the 323 
relative abundances (RA) in the controls along time were compared with the RA in BPS 324 
submitted to the different PPCP treatments. In all BPS microcosms Alphaproteobacteria 325 
(19.9-40.1% RA) decreased during the first 14 days of incubation, but increased 326 
significantly in those exposed to IBP (ANOVA, p < 0.05) (Fig. 2A). The 327 
alphaproteobacterial orders Rhodobacterales and Rickettsiales were enriched in all 328 
cases along time, but were significantly reduced in those BPS treated with TCS or the 329 
mixture of PPCPs (Fig. S2). Within the order of Rhodobacterales, the dominant family 330 
Hyphomonadaceae (Fig. 4) was affected in a similar manner by IBP, TCS and by the 331 
PPCP mixture, indicating that this family is sensitive to these contaminants, but less so 332 
to DCF. The RA of the order Caulobacterales, (Fig. S2) was positively affected by IBP, 333 
and especially by TCS or the mix of PPCPs with a significant (ANOVA, p < 0.05) 334 
increase of 0.9-2% with respect to the control. The abundance of the family 335 
Caulobacteraceae (Fig. 4), increased by 1-2% at 14-28 days with TCS and the PPCPs 336 
mixture. Interestingly, microorganisms belonging to this family have been found to be 337 
involved in the degradation of other organic pollutants such as diclofop-methyl and 338 
phenanthrene (Zhang, H. et al., 2018; Lu, C. et al., 2019). In the current study, the 339 
observed enrichment within this family was mainly due to two OTUs (JN868839.1.1481 340 
and FPLS01017875.18.1484) belonging to the genera Brevundimonas and Caulobacter, 341 
respectively, indicating that these caulobacterial genera may have some resistance to 342 
TCS. In the case of members of Rhizobiales (Fig. S2), exposure to IBP or TCS 343 
increased the RA compared to the control microcosms at 28 days and 7 days, 344 
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respectively. Nevertheless, DCF had a significant negative effect at 28 days (ANOVA, 345 
p < 0.05). However, the dominant families of this order, Hyphomicrobiaceae and 346 
Rhizobiaceae (Fig. 4), tend to increase in those BPS contaminated with the PPCP 347 
mixture at the end of the incubation period when the concentrations had lowered 348 
substantially. Exposure to IBP also significantly increased the RA of members of 349 
Sphingomonadales at 14 days (Fig. S2), while for DCF, TCS and for the PPCPs 350 
mixture, the RA decreased with respect to the control after 21 days, and especially after 351 
28 days. In the same manner, treatment with IBP caused an increment in the family 352 
Sphingomonadaceae whose RA increased between 1-2% at 7, 14 and 50 days (Fig. 4). 353 
This increase is mainly associated to enrichment of the genus Novosphingobium. 354 
Recently, Navrozidou et al. (2019) reported that Novosphingobium was a predominant 355 
genus in activated sludge after application of a high dose of ibuprofen. Therefore, this 356 
genus is likely to metabolize this PPCP. IBP-exposed microcosms were also enriched in 357 
Sphingobium and Sphingomonas species at 7 and 50 days. Previous studies have 358 
demonstrated that specialized microbiota belonging to these genera were capable of 359 
degrading PPCPs (Zhou et al., 2013). In fact, Murdoch and Hay (2005) obtained an 360 
isolate from activated sewage sludge, Sphingomonas sp. strain Ibu-2, with the ability to 361 
use IBP as a sole carbon and energy source. This capacity is associated with a five-gene 362 
cluster, ipfABDEF, which is involved in the transformation of ibuprofen to 363 
isobutylcatechol, an alkylcatechol intermediate which bacteria may use for growth 364 
(Murdoch and Hay, 2013). Similar genes have been observed in a strain belonging to 365 
the alphaproteobacterial family Rhodospirillaceae (Żur et al., 2018), although generally 366 
the RA of this family was reduced in IBP- exposed BPS (Fig. 4).  367 
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The relative abundance of Betaproteobacteria increased with time in all BPS 368 
microcosms except in those treated with TCS. Within this class, microorganisms of the 369 
order Methylophilales were mostly negatively impacted by TCS, showing a reduction in 370 
the RA of 0.4-1% (Fig. S3A). However, the RA of Burkholderiales increased 371 
significantly (ANOVA, p < 0.05) with respect to the control at several time periods with 372 
IBP, DCF and the PPCPs mixture, but not when exposed to TCS. Interestingly, strains 373 
belonging to this order have been found which harbour genes sharing similarity up to 76 374 
% to known ibuprofen degradation genes (Żur et al., 2018), or with the capacity to 375 
transform this compound (Murdoch and Hay, 2015). 376 
On the other hand, the RA of Gammaproteobacteria decreased in the control BPS and 377 
in those contaminated with TCS while it increased at punctual moments in the BPS 378 
exposed to IBP, DCF or the PPCP mixture (Fig. 2A). In the case of the order 379 
Legionellales, the relative abundance was 2.3 and 3.3 -fold lower in the BPSs exposed 380 
to TCS at 28 and 50 days compared to controls, suggesting that members of this order 381 
are sensitive even to low concentrations of this PPCP. However, DCF treatment caused 382 
the opposite effect, pointing to tolerance to this contaminant (Fig. S3B). The 383 
gammaproteobacterial order Xanthomonadales showed a decrease at 50 days in the 384 
BPSs exposed to IBP when it was no longer present in the system but increased at 385 
several time points with DCF and the PPCP mixture. Within this order, the family 386 
Xanthomonadaceae was enriched at intermediate time points with IBP, DCF, TCS and 387 
especially when the three contaminants were applied as a mixture (Fig. 4), suggesting 388 
that members of this family are resistant or can metabolize these PPCPs. Interestingly, 389 
species of this family have been determined as potential degraders of IBP, DCF, and 390 
naproxen (Lu, Z. et al., 2019). Oh et al. (2019) also found enrichment of 391 
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Xanthomonadaceae in TCS -amended activated sludge reactors, specifically of the 392 
genus Pseudoxanothomonas. Żur et al. (2018) reported that Pseudoxanthomonas spadix 393 
BD-a59, a species with the ability to degrade all six BTEX (benzene, toluene, 394 
ethylbenzene, and o-, m-, and p-xylene) compounds, has a gene cluster with a high 395 
similarity with ibuprofen degradation genes ipfABDEF. Genera affected by PPCP -396 
treated BPSs included the xanthomonal genus Luteimonas, whose abundance increased 397 
up to 2.5% especially with IBP and DCF (data not shown). Recently, Cydzik-398 
Kwiatkowska and Zielińska (2018) reported that this genus could play an important role 399 
in the bioremoval of the emerging contaminant, bisphenol A. The abundance of another 400 
dominant gammaproteobacterial family, Pseudomonadaceae, increased but not 401 
significantly in the IBP -contaminated microcosms by 0.9% and 0.8% at 7 and 21 days, 402 
respectively; and more substantially with the PPCP mixture at 14 days (Fig. 4), 403 
especially with regard to the genus Pseudomonas.  404 
Within the decrease of the RA of the phylum Bacteroidetes observed with time, 405 
exposure to IBP and DCF induced a relatively stronger negative effect by decreasing 406 
significantly (ANOVA, p < 0.05) by 3.8-15.6% and 8.3-11.3%, respectively (Fig. 2A). 407 
Similarly, these contaminants negatively affected Saprospirae, one of the most 408 
abundant classes of this phylum (Fig. S4). In contrast, the RA of the bacteroidetal class 409 
Sphingobacteriia was higher after treatment with the PPCPs studied, especially in the 410 
TCS contaminated BPS, and when applied as a mixture, showing a significant 411 
(ANOVA, p < 0.05) increase in RA of 0.5-2.4% (Fig. S4). This enrichment was 412 
reflected by the dominant family Sphingobacteriaceae, especially of the abundant OTU 413 
AB267714.1.1482 belonging to the genus Olivibacter. Strains belonging to this genus 414 
have been found to be involved in the degradation of phenanthrene (Villaverde et al., 415 
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2019) or diphenol (Ntougias et al., 2014). On the other hand, treatment with TCS 416 
caused a decline in members of the class Cytophagia at 14 and 21 days by 3.4% and 417 
3.9% respectively, but then increased by 6.5% at day 50 (Fig. S4), indicating a possible 418 
sensitivity of this class to TCS until concentrations decline to below the 10 mg kg-1 419 
level. The most abundant bacteroidetal family in all BPSs was Chitinophagaceae, 420 
whose abundance decreased with time, especially in microcosms exposed to IBP and 421 
DCF (Fig. 4), although it was relatively unaffected in the TCS-exposed microcosms. 422 
PPCP application showed a significant (ANOVA, p < 0.05) increase in the abundance 423 
of the flavobacterial family Cyclobacteriaceae of which strains have been isolated from 424 
saline environments including oil-contaminated fields (Hu et al., 2015), but which have 425 
not been associated previously with PPCPs. A general decrease in Bacteroidetes was 426 
also observed in other studies with BPSs exposed to pesticides (Dealtry et al., 2016; 427 
Holmsgaard et al., 2017).  428 
The RA of the phylum Acidobacteria increased over time in all BPS microcosms except 429 
in those contaminated with TCS individually or in mixture and in which its abundance 430 
was drastically reduced at 28 and 50 days of incubation (Fig. 2A). Within this phylum, 431 
the RA of the class Acidobacteria-6 was 5 and 7- fold higher in control samples than in 432 
samples treated with TCS or the mix of PPCPs at 50 days, respectively (Fig. S5). 433 
Moreover, TCS treatment prevented the enrichment of the class Chloracidobacteria. 434 
This biocide negatively affected microorganisms of these two classes of Acidobacteria, 435 
especially the OTUs MEDJ01000003.85717.87273 and JN869200.1.1518 belonging to 436 
the families RB40 and Ellin6075, respectively.  437 
The phyla Verrumicrobia showed enrichment during the incubation period. However, 438 
this increment was by 2- fold less pronounced in BPSs exposed to TCS, compared to 439 
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control conditions (Fig. 2A). The abundance of the class Methylacidiphilae was 440 
significantly (ANOVA, p < 0.05) reduced by 0.9-1% after 21 or more days of exposure 441 
to TCS or the mixture of PPCPs (Fig. S6A), mainly affecting the family LD19. In 442 
contrast, the application of IBP caused enrichment of Verrumicrobia (Fig. 2A), 443 
especially increasing the abundance of the class Verrucomicrobiae by between 0.6-1% 444 
at 21 and 28 days. The same effect occurred after 21 days when all three PPCPs were 445 
added in mixture (Fig. S6A). However, the dominant verrumicrobial family 446 
Verrucomicrobiaceae, only showed substantial increases at the end of the incubation 447 
period in those BPSs contaminated with IBP and the PPCP mixture (Fig 4).  448 
The RA of the phylum Planctomycetes increased in all the BPS microcosms during the 449 
incubation period (Fig. 2A). Recently, Zhang, S. et al. (2018) determined that 450 
Planctomycetes together with Proteobacteria were the most abundant phyla in 451 
biologically active filters exhibiting efficient removal of emerging contaminants. The 452 
RA observed for the major planctomycetal class Planctomycetia showed trends similar 453 
to the phylum on the whole (Fig. S6B). However, the most dominant family belonging 454 
to this class, Pirellulaceae, showed enrichment at longer incubation times in BPSs 455 
exposed to TCS or the PPCP mixture compared to the control BPS (Fig. 4). On the 456 
other hand, the enrichment of the planctomycetal class Phycisphaerae observed in the 457 
control was more pronounced in the BPSs exposed to IBP, but relatively less prominent 458 
in samples treated with TCS or the PPCP mixture (Fig. S6B).  459 
The RA of the phylum Actinobacteria showed an increasing trend in all the BPS 460 
microcosms (Fig. 2A), although in the IBP and DCF treated BPSs there was a greater 461 
increase at 14 days compared to the control BPS. Within this phylum, the RA of 462 
Promicromonosporaceae generally increased in all PPCP treatments after 14 and 21 463 
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days of incubation (Fig. 4). These increments were mainly associated to the OTU 464 
BBGM01000056.204.1722 belonging to the genus Cellulosimicrobium. 465 
Finally, in order to verify the results of the community analysis based on 16S rRNA 466 
sequences, the abundance of some of the taxa most affected by contamination with 467 
PPCPs (Alpha-, Beta-, Gammaproteobacteria and Acidobacteria) was quantified by 468 
real-time PCR assays (Table S1). As expected, no significant difference in the 469 
abundance of Alpha-, and Gammaproteobacteria at the class level was observed in any 470 
microcosms between the initial (7 days) and final (50 days) time points. Nevertheless, 471 
the bacteria belonging to the Betaproteobacteria class were enriched in BPS 472 
microcosms after contamination with IBP or DCF but not the BPSs exposed to TCS or 473 
the PPCP mixture. Moreover, in accordance with the 16S rRNA community study 474 
results, the abundance of the phylum Acidobacteria increased in control samples and in 475 
the microcosms treated with IBP and DCF, but no significant differences were observed 476 
in the TCS-exposed microcosms. Therefore, the results obtained by qPCR analysis were 477 
consistent with 16S rRNA gene sequencing data. 478 
3.3. Toxicological study 479 
In order to discern whether the PPCPs at the concentrations used in this study have a 480 
lethal effect on the total bacterial populations in the BPS microcosms, the number of 481 
live bacterial cells was determined by the LIVE/DEAD® microscopic technique (Fig. 482 
5). Before contamination, the number of live bacterial cells in the BPS was 1.03 x 109 ± 483 
5.48 x 107 cells/g. Throughout the incubation period, the number of cells in the BPSs 484 
treated with IBP or DCF was not significantly different than in the non-contaminated 485 
BPS microcosm (Control). However, after 7 and 14 days, the BPS exposed to TCS 486 
contained 43% and 34% less live bacterial cells, respectively, than the control BPS 487 
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(ANOVA, p > 0.01) before recovering at later periods. This may be due to the fact that 488 
the TCS exposed BPS still contained more than 65% of the initially applied biocide at 489 
these times. Nevertheless, when the three PPCPs were applied in mixture, the observed 490 
decrease in viability during the same period was not significant. These results suggest 491 
that the bactericidal effect of TCS is related to its concentration in the BPS although the 492 
bacterial community recovered with time. On the other hand, the lethal effect of TCS 493 
was mitigated in BPS contaminated with the three PPCPs, possibly due to the increase 494 
of resistant populations induced by IBP and/or DCF. Further studies with different 495 
concentrations will be needed to determine toxicity limits of the PPCPs in BPS.  496 
 497 
4. Conclusions 498 
The BPS system is effective in dissipating PPCPs, especially IBP followed by DCF. 499 
However, dissipation of DCF is slowed down when the PPCPs are applied as a mixture. 500 
This may be due to the negative impact of TCS on some of the bacterial groups. The 501 
PPCPs affect the bacterial community although the incubation time is the major driver. 502 
Of the three PPCPs, TCS had the most negative impact on bacterial viability and the 503 
community, probably due to its antiseptic effect even at relatively low concentrations. 504 
Nevertheless, the relative abundance of certain bacterial taxa increased with all the 505 
PPCPs. Our results suggest that BPSs after the treatments with IBP, DCF and TCS can 506 
maintain high bacterial community diversity despite the contamination levels and 507 
biocide agents added. It would be interesting in future works to determine which 508 
mechanisms are used by members of the most resistant taxa to detoxify these PPCPs. 509 
Altogether, the ecotoxicity and effect on bacterial communities by the PPCPs studied, 510 
especially TCS, should be taken into account not only for techniques which could be 511 
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used to eliminate PPCPs from effluents but also for the ecological effects of low 512 
concentrations in the environment. 513 
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Figure 1. Dissipation of ibuprofen, diclofenac and triclosan applied separately or in 752 
mixture in non-sterilized (black symbols) and sterilized (white symbols) BPS 753 
microcosms. Lines represent the model fit to experimental data. Error bars indicate 754 
standard deviation (n=3). 755 
 756 
 757 





Figure 2. Relative abundance of the most dominant phyla (>1% in any sample) and 761 
classes of Proteobacteria at different incubation times (days) in non-contaminated 762 
(control) and contaminated BPS microcosms with ibuprofen, diclofenac and triclosan, 763 
applied separately or in mixture (A). Hierarchical cluster analysis of the bacterial 764 
community composition based on Bray-Curtis distances (B).  765 
 766 




Figure 3. Principal coordinates analysis of bacterial communities in the BPS 769 
microcosms based on Bray-Curtis distances (A). Nonmetric Multidimensional Scaling 770 
(NMDS) ordination of the bacterial community composition based on Bray-Curtis 771 
distances with data constrained to the most dominant phyla (B). The numbers in red 772 





Figure 4. Heatmap of the most dominant families (>2% in any sample) in non-776 
contaminated (control) and BPS microcosms contaminated with ibuprofen, diclofenac 777 
and triclosan, applied separately or in mixture at different incubation times (days). 778 
*Significant differences among non-contaminated and contaminated BPS samples 779 
(ANOVA homogeneity test; p < 0.05). 780 
 781 





Figure 5. Number of live bacterial cells determined using the LIVE/DEAD® 785 
BacLight™ Bacterial Viability Kit per gram of non-contaminated (control) and BPS 786 
microcosm contaminated with ibuprofen, diclofenac and triclosan, applied separately or 787 
in mixture at different incubation times. The number of live bacterial cells in the BPS 788 
was initially 1.03 x 109 ± 5.48 x 107 cells/g. *Significant differences among non-789 
contaminated and contaminated BPS samples (ANOVA homogeneity test; p < 0.01). 790 
Error bars represent the standard error for each sample (n>2). 791 
 792 
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Figure S1. Rarefaction curves for the Operational Taxonomic Units (OTUs) of the non-811 
contaminated (control) and contaminated BPS samples with ibuprofen, diclofenac and 812 
triclosan, applied separately and in mixture (A). Nonmetric Multidimensional Scaling 813 
(NMDS) ordination of the bacterial community composition based on Bray-Curtis 814 
distances. The numbers in red indicate the incubation time (days) (B). 815 




Figure S2. Relative abundance of different orders within the class Alphaproteobacteria. 818 
*Significant differences among non-contaminated (control) and contaminated BPS 819 
samples with ibuprofen, diclofenac and triclosan, applied separately and in mixture 820 
(ANOVA homogeneity test; p < 0.05). Error bars represent the standard error for each 821 
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Figure S3. Relative abundance of different orders within the classes Betaproteobacteria 824 
(A) and Gammaproteobacteria (B). *Significant differences among non-contaminated 825 
(control) and contaminated BPS samples with ibuprofen, diclofenac and triclosan, 826 
applied separately and in mixture (ANOVA homogeneity test; p < 0.05). Error bars 827 
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Figure S4. Relative abundance of the most representative classes within the phylum 830 
Bacteroidetes. *Significant differences among non-contaminated (control) and 831 
contaminated BPS samples with ibuprofen, diclofenac and triclosan, applied separately 832 
and in mixture (ANOVA homogeneity test; p < 0.05). Error bars represent the standard 833 
error for each sample (n=3). 834 
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Figure S5. Relative abundance the most representative classes within the phylum 837 
Acidobacteria. *Significant differences among non-contaminated (control) and 838 
contaminated BPS samples with ibuprofen, diclofenac and triclosan, applied separately 839 
and in mixture (ANOVA homogeneity test; p < 0.05). Error bars represent the standard 840 
error for each sample (n=3). 841 
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Figure S6. Relative abundance the most representative classes within the phyla 844 
Verrumicrobia (A) and Planctomycetes (B). *Significant differences among non-845 
contaminated (control) and contaminated BPS samples with ibuprofen, diclofenac and 846 
triclosan, applied separately and in mixture (ANOVA homogeneity test; p < 0.05). Error 847 
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Table S1. Gene copy number per nanogram of DNA of the different taxa from non-851 
contaminated (control) and contaminated BPS samples with ibuprofen, diclofenac and 852 
triclosan, applied separately and in mixture at 0, 7 and 50 days of the incubation period. 853 
Standard errors (in parentheses) are given. Letters indicate significant differences 854 
among samples of different incubation times of each treatment and taxa (ANOVA 855 
homogeneity test; p < 0.05). 856 
 857 
   Taxa 
Treatment Days Total bacteria α-Proteobacteria β-Proteobacteria γ-Proteobacteria Acidobacteria 
 0 2.93 x 10
5 
(0.65)a 1.92 x 10
5 
(0.42)a 1.73 x 10
3 
(0.57)a 1.47 x 10
5 
(0.53)a 1.12 x 10
3 
(0.34)a 
       
Control 7 7.28 x 10
5 
(1.05)a 4.08 x 10
5 
(0.76)a 9.35 x 10
3 
(2.14)a 3.27 x 10
5 
(0.32)a 1.56 x 10
4 
(0.26)a 
 50 5.16 x 10
5 
(0.35)a 3.03 x 10
5 
(0.19)a 7.47 x 10
3 
(2.25)a 9.18 x 10
4 
(2.46)a 5.84 x 10
4 
(1.07)b 
       
Ibuprofen 7 1.06 x 10
6 
(0.01)b 1.93 x 10
5 
(0.50)a 3.30 x 10
3 
(0.25)a 2.39 x 10
5 
(0.23)a 5.27 x 10
3 
(1.27)a 
 50 4.65 x 10
5 
(0.34)a 3.11 x 10
5 
(0.21)a 1.26 x 10
4
 (0.01)b 1.44 x 10
5 
(0.06)a 7.37 x 10
4 
(0.29)b 
       
Diclofenac 7 9.05 x 10
5 
(0.10)b 2.64 x 10
5 
(0.17)a 2.01 x 10
3 
(0.04)a 1.26 x 10
5 
(0.27)a 2.85 x 10
3 
(0.34)a 
 50 5.44 x 10
5 
(0.09)a 3.92 x 10
5 
(0.28)a 1.73 x 10
4 
(0.31)b 1.65 x 10
5 
(0.04)a 8.84 x 10
4 
(0.82)b 
       
Triclosan 7 1.19 x 10
6
 (0.12)b 3.76 x 10
5 
(0.78)a 1.06 x 10
4 
(0.57)a 3.46 x 10
5 
(1.16)a 1.83 x 10
4 
(0.69)a 
 50 4.93 x 10
5
 (0.15)a 3.90 x 10
5 
(0.32)a 1.07 x 10
4 
(0.07)a 1.95 x 10
5 
(0.21)a 2.46 x 10
4 
(0.29)a 
       
Mix 7 6.41 x 10
5
(0.57)a 3.34 x 10
5 
(0.26)a 4.78 x 10
3 
(0.33)a 1.83 x 10
5 
(0.06)a 1.82 x 10
4 
(0.37)a 
 50 5.05 x 10
5
 (0.47)a 2.72 x 10
5 
(0.24)a 5.04 x 10
3 
(1.08)a 1.34 x 10
5 
(0.34)a 1.18 x 10
4 
(0.22)a 
 858 
 859 
